Galectin Therapeutics Price Chart
Galectin Therapeutics Volume Chart
Galectin Therapeutics Market Segments
Regular Trading Hours
-0.02(-0.66%)
| Open | $2.29 |
|---|---|
| Close | $2.28 |
| Low | $2.21 |
| Low Change | -0.09 (-3.71%) |
| High | $2.30 |
| High Change | +0.01 (+0.44%) |
| Range | $0.10 |
| Volume | 127.654K |
| Dollar Volume | $290.41K |
Premarket
+0.00(+0.00%)
| Open | $2.35 |
|---|---|
| Close | $2.35 |
| Low | $2.35 |
| Low Change | 0.00 (0.00%) |
| High | $2.35 |
| High Change | +0.00 (+0.00%) |
| Range | $0.00 |
| Volume | 3K |
| Dollar Volume | $7.05K |
After Hours Yesterday
*No Trades in Segment
Regular Trading Hours Yesterday
-0.02(-0.88%)
| Open | $2.28 |
|---|---|
| Close | $2.26 |
| Low | $2.23 |
| Low Change | -0.06 (-2.41%) |
| High | $2.35 |
| High Change | +0.07 (+3.07%) |
| Range | $0.13 |
| Volume | 281.145K |
| Dollar Volume | $635.39K |
Premarket Yesterday
-0.04(-1.57%)
| Open | $2.36 |
|---|---|
| Close | $2.32 |
| Low | $2.32 |
| Low Change | -0.04 (-1.57%) |
| High | $2.36 |
| High Change | +0.00 (+0.00%) |
| Range | $0.04 |
| Volume | 800 |
| Dollar Volume | $1.86K |
Galectin Therapeutics Moving Averages
| 5 Day Moving Average (SMA5) | $2.31 |
|---|---|
| 10 Day Moving Average (SMA10) | $2.33 |
| 20 Day Moving Average (SMA20) | $2.37 |
| 50 Day Moving Average (SMA50) | $2.73 |
| 100 Day Moving Average (SMA100) | $3.29 |
| 200 Day Moving Average (SMA200) | $3.94 |
Galectin Therapeutics Statistics
| Average Volume (30 Days) | 311.08K |
|---|---|
| P/E Ratio (Current) | -4.94 |
| EPS (Current) | -$0.47 |
| Dividend Yield | 0.00% |
| Free Cash Flow | — |
| Cash Ratio | 2.21 |
| Current Ratio | 2.42 |
| Quick Ratio | 2.42 |
| Debt to Equity | -0.26 |
| Enterprise Value | $167.70M |
| EV to EBITDA | -8.35 |
| EV to Sales | — |
| Price to Book | -1.19 |
| Price to Cash Flow | — |
| Price to Free Cash Flow | — |
| Price to Sales | — |
| Return on Assets | -1.59% |
| Return on Equity | 0.24% |
Galectin Therapeutics Stock Splits
There has been 1 stock split for Galectin Therapeutics (GALT). The reverse stock split occured on March 23, 2012 and reduced the outstanding shares at a ratio of 6:1.
| Date | Type | Ratio |
|---|---|---|
| Mar 23, 2012 | Reverse | 6:1 |
Galectin Therapeutics Dividends
There have been no dividends for Galectin Therapeutics (GALT).